Plain-English translation of NCT05738330 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
The SMaRRT-HD trial is testing a new way to help people on hemodialysis feel better by catching and treating symptoms early. Some dialysis clinics will use a tablet-based symptom tracking system where you report how you're feeling, and your care team gets alerts to help manage any problems you mention. Other clinics will continue with their usual approach to checking in about symptoms.
Many people on dialysis suffer from symptoms—like fatigue, nausea, or pain—that go unrecognized or untreated because there's no regular, structured way to talk about them. This trial tests whether this new treatment approach can reduce that suffering and improve communication between patients and their care teams.
You likely qualify if…
You likely don't qualify if…
If your clinic is selected for the new system, you will use a tablet at your dialysis clinic to report how you're feeling on a regular basis. Your care team will see alerts about your symptoms and provide guidance to help manage them, and they'll share progress reports with you. If your clinic is in the usual care group, you'll continue receiving standard symptom monitoring through regular conversations with your team. The study lasts about 12 months.
AI-generated summary from trial data · Jun 6, 2026 · Not medical advice
United States